Orchid to expand business with an investment of $90 millionIllustrative image – not actual.

Orchid Chemicals & Pharmaceuticals plans to invest $90 million (Rs.405 crore, approx.) to triple its business over a period of four years.

 

About $70 million of the proposed funds would be brought in as equity, while the remaining $20 million would be brought in through internal accruals of the company.

 

The company plans to invest funds in areas such as widening its cephalosporin business, foraying into non-cephalosporin drugs like central nervous system and cardiovascular drugs, new drug delivery and discovery systems, formulations and bio-enzymes and bio-transformation research.

← All latest storiesBack to top →